Potential of natural products in combination with arsenic trioxide: Investigating cardioprotective effects and mechanisms
Open Access
- 13 April 2023
- journal article
- review article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 162, 114464
Abstract
No abstract availableKeywords
Funding Information
- National Key Research and Development Program of China (2020YFC2002701)
- National Natural Science Foundation of China (81974556)
This publication has 219 references indexed in Scilit:
- Dietaryω-3 Polyunsaturated Fatty Acid DHA: A Potential Adjuvant in the Treatment of CancerBioMed Research International, 2013
- Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell DeathCell, 2012
- Flavonoid engineering of flax potentiate its biotechnological applicationBMC Biotechnology, 2011
- Resveratrol, an activator of SIRT1, upregulates sarcoplasmic calcium ATPase and improves cardiac function in diabetic cardiomyopathyAmerican Journal of Physiology-Heart and Circulatory Physiology, 2010
- Salvianolic acid B inhibits growth of head and neck squamous cell carcinoma in vitro and in vivovia cyclooxygenase‐2 and apoptotic pathwaysInternational Journal of Cancer, 2009
- Multi-targeted therapy of cancer by omega-3 fatty acidsCancer Letters, 2008
- Resveratrol protects against arsenic trioxide‐induced cardiotoxicity in vitro and in vivoBritish Journal of Pharmacology, 2008
- Prevention of isoproterenol-induced cardiac hypertrophy by eugenol, an antioxidantIndian Journal of Clinical Biochemistry, 2006
- Endoplasmic reticulum stress: cell life and death decisionsJournal of Clinical Investigation, 2005
- 2- and 3-Substituted 1,4-Naphthoquinone Derivatives as Subversive Substrates of Trypanothione Reductase and Lipoamide Dehydrogenase from Trypanosoma cruzi: Synthesis and Correlation between Redox Cycling Activities and in Vitro CytotoxicityJournal of Medicinal Chemistry, 2001